BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15965236)

  • 1. Fas binding to calmodulin regulates apoptosis in osteoclasts.
    Wu X; Ahn EY; McKenna MA; Yeo H; McDonald JM
    J Biol Chem; 2005 Aug; 280(33):29964-70. PubMed ID: 15965236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calmodulin in the regulation of osteoclastogenesis.
    Zhang L; Feng X; McDonald JM
    Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of avian osteoclastic H+ -ATPase and bone resorption by tamoxifen and calmodulin antagonists. Effects independent of steroid receptors.
    Williams JP; Blair HC; McKenna MA; Jordan SE; McDonald JM
    J Biol Chem; 1996 May; 271(21):12488-95. PubMed ID: 8647856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis.
    Micoli KJ; Pan G; Wu Y; Williams JP; Cook WJ; McDonald JM
    J Biol Chem; 2000 Jan; 275(2):1233-40. PubMed ID: 10625668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
    Pan G; Vickers SM; Pickens A; Phillips JO; Ying W; Thompson JA; Siegal GP; McDonald JM
    Am J Pathol; 1999 Jul; 155(1):193-203. PubMed ID: 10393851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
    Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
    J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study.
    Fancy RM; Wang L; Napier T; Lin J; Jing G; Lucius AL; McDonald JM; Zhou T; Song Y
    Biochemistry; 2014 Apr; 53(16):2680-8. PubMed ID: 24702583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calmodulin in HIV-potentiated Fas-mediated apoptosis.
    Pan Z; Radding W; Zhou T; Hunter E; Mountz J; McDonald JM
    Am J Pathol; 1996 Sep; 149(3):903-10. PubMed ID: 8780394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin binding to the Fas death domain. Regulation by Fas activation.
    Ahn EY; Lim ST; Cook WJ; McDonald JM
    J Biol Chem; 2004 Feb; 279(7):5661-6. PubMed ID: 14594800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
    Williams JP; McDonald JM; McKenna MA; Jordan SE; Radding W; Blair HC
    J Cell Biochem; 1997 Sep; 66(3):358-69. PubMed ID: 9257192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
    Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
    J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast apoptosis: the role of Fas in vivo and in vitro.
    Wu X; McKenna MA; Feng X; Nagy TR; McDonald JM
    Endocrinology; 2003 Dec; 144(12):5545-55. PubMed ID: 12960091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
    Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
    J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin.
    Williams JP; McKenna MA; Thames AM; McDonald JM
    Biochem Cell Biol; 2000; 78(6):715-23. PubMed ID: 11206583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.
    Frankfurt OS; Sugarbaker EV; Robb JA; Villa L
    Cancer Lett; 1995 Nov; 97(2):149-54. PubMed ID: 7497456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.
    Ahn EY; Pan G; Oh JH; Tytler EM; McDonald JM
    Am J Pathol; 2003 Nov; 163(5):2053-63. PubMed ID: 14578204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival.
    Seales EC; Micoli KJ; McDonald JM
    J Cell Biochem; 2006 Jan; 97(1):45-55. PubMed ID: 16216008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.